Status:
COMPLETED
In-patient Study in Patients With Type 2 Diabetes Mellitus
Lead Sponsor:
GlaxoSmithKline
Conditions:
Type 2 Diabetes Mellitus
Diabetes Mellitus, Type 2
Eligibility:
All Genders
18-66 years
Phase:
PHASE1
Brief Summary
This study is a placebo-controlled study in both healthy normal subjects and patients with Type 2 Diabetes Mellitus to assess the levels of exenatide in the bloodstream when it is given for 7 days, an...
Eligibility Criteria
Inclusion
- have type 2 diabetes mellitus that has been diagnosed for at least three months
- must be taking either (1) no medication for their diabetes or (2) taking metformin, a sulfonylurea, or metformin and a sulfonylurea
- must be willing to wash-out of these medications for 14 days prior to the start of the study
- must have bloodwork that meets certain criteria (for example, total cholesterol \< 240 mg/dL)
Exclusion
- must not have any other major illness other than diabetes
Key Trial Info
Start Date :
October 1 2005
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00259896
Start Date
October 1 2005
Last Update
June 4 2012
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.